Why Evolution Road?

In our ten-year experience developing, scaling, and optimizing digital marketing programs, we have generated over $1.4 billion for our clients at an average ROI of 4:1 across all brands, all programs, and all costs.

The pharmaceutical marketing and sales landscape is undergoing massive change. Conventional DTC mass advertising, while very important, faces tremendous pressure. The industry’s sales rep field forces are shrinking rapidly, and having increased difficulty reaching target healthcare professionals. Pressures from managed care have intensified, and marketing budgets are under pressure as well. And adding to the volatility is a dynamically changing media environment. Patients and physicians alike increasingly turned toward an exponentially expanding array of digital channels for health information, connections and communication.

Yet throughout this constant change, Evolution Road provides the marketing innovation needed to adapt and grow brands in this dynamic environment. We created the leading pharmaceutical digital marketing ROI methodology in the industry, together with comScore,— and also developed the widely used e-marketing effectiveness benchmarks, which allow mission-critical decisions based on actual data rather than intuition alone.

In recognition of our continued leadership, the president of Evolution Road, Paul Ivans, will chair this year’s ePharma Summit, the largest pharmaceutical digital marketing and innovation conference in the industry, for the seventh year in a row. He is also a frequent speaker at industry events and has contributed to such prominent industry publications as Medical Marketing & Media, DTC Perspectives, and ePharmaceuticals.

As for our vision of the future, it includes continuing to drive brand growth leveraging the increasingly complex and interdependent digital channels. Tactics will multiply and become more complex, and the focus on outcomes will sharpen.

Having the knowledge and experience to plan, optimize, measure and scale these efforts will be key to raise brand awareness and favorability, as well as generate incremental new patient starts, and increase adherence, and drive share and sales. This has been our focus for more than a decade, and we will continue to improve health and business outcomes in the future.